The AmerisourceBergen Foundation–NCPA Foundation Disaster Relief Grant Fund will support community pharmacies affected by disasters and other adverse circumstances.
Olopatadine hydrochloride ophthalmic solution, 0.2%, had a market value of $62 million for the 12 months ending December 2018, according to IQVIA data.
The Food and Drug Administration is providing final guidance on the pathway for “interchangeable” biologics, which may be substituted without the involvement of the prescriber.